Related Experiment Video
Updated: Aug 14, 2026

Evaluation of Caspase Activation to Assess Innate Immune Cell Death
Published on: January 20, 2023
Simvastatin induces caspase-independent apoptosis in LPS-activated RAW264.7 macrophage cells
Yong Chan Kim1, Seok Bean Song, Mi Hee Lee
1Department of Biochemistry, College of Natural Sciences, Chungnam National University, 220 Gung-dong Yuseong-gu, Daejeon 305-764, Republic of Korea.
Abstract:
Macrophages participate in several inflammatory pathologies such as sepsis and arthritis. We examined the effect of simvastatin on the LPS-induced proinflammatory macrophage RAW264.7 cells. Co-treatment of LPS and a non-toxic dose of simvastatin induced cell death in RAW264.7 cells. The cell death was accompanied by disruption of mitochondrial membrane potential (MMP), genomic DNA fragmentation, and caspase-3 activation. Surprisingly, despite caspase-dependent apoptotic cascade being completely blocked by Z-VAD-fmk, a pan-caspase inhibitor, the cell death was only partially repressed. In the presence of Z-VAD-fmk, DNA fragmentation was blocked, but DNA condensation, disruption of MMP, and nuclear translocation of apoptosis inducing factor were obvious. The cell death by simvastatin and LPS was effectively decreased by both the FPP and GGPP treatments as well as mevalonate. Our findings indicate that simvastatin triggers the cell death of LPS-treated RAW264.7 cells through both caspase-dependent and -independent apoptotic pathways, suggesting a novel mechanism of statins for the severe inflammatory disease therapy.
Insights
Simvastatin induces programmed cell death in macrophages via both caspase-dependent and -independent pathways. This finding suggests a new therapeutic strategy for severe inflammatory diseases like sepsis and arthritis.
Area of Science:
- Immunology
- Cell Biology
- Pharmacology
Background:
- Macrophages are key players in inflammatory diseases such as sepsis and arthritis.
- Lipopolysaccharide (LPS) is a potent inducer of pro-inflammatory responses in macrophages.
Purpose of the Study:
- To investigate the effects of simvastatin on LPS-induced pro-inflammatory macrophage RAW264.7 cells.
- To elucidate the mechanisms underlying simvastatin-induced cell death in these cells.
Main Methods:
- RAW264.7 cells were treated with LPS and simvastatin.
- Cell death, mitochondrial membrane potential (MMP), DNA fragmentation, and caspase-3 activation were assessed.
- The role of caspases was evaluated using a pan-caspase inhibitor (Z-VAD-fmk).
- The impact of mevalonate pathway intermediates (FPP, GGPP) and mevalonate was examined.
Main Results:
- Simvastatin, in combination with LPS, induced cell death in RAW264.7 cells.
- This cell death involved disruption of MMP, DNA fragmentation, and caspase-3 activation.
- A portion of the cell death occurred independently of caspases, evidenced by partial repression with Z-VAD-fmk.
- Caspaase-independent death involved DNA condensation and MMP disruption.
- Cell death was attenuated by FPP, GGPP, and mevalonate treatments.
Conclusions:
- Simvastatin triggers LPS-treated macrophage cell death through both caspase-dependent and -independent apoptotic pathways.
- This dual mechanism highlights a novel therapeutic potential for statins in managing severe inflammatory conditions.
- Understanding these pathways could lead to new treatments for sepsis and arthritis.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Cellular Injury V: Apoptosis and Autophagy
The Intrinsic Apoptotic Pathway
Apoptosis

